⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago
🛡️ EUSW
🇬🇧
🧸 Product UNITED KINGDOM IN RESPEC March 6, 2026

Bajaj — Almond Drops

Hair oil, 200 ml. Manufacturing date: 03/2022.

📷 Safety Gate / European Commission · Source
Bajaj — Almond Drops
📷 Safety Gate / European Commission · Source
Risk level
Serious risk
Type
Chemical
Category
Cosmetics
Hazard
The product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation.
Origin
India

⚖️ Actions ordered by authorities

  • (to: Retailer) Other: Seizure of Goods
  • (to: Retailer) Destruction of the product
Barcode (GTIN): 8906014765251
🗄
Archived (older alert)
This alert was reported 82 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
10 days in total
May 17, 2026 May 27, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? Bajaj Almond Drops is a cosmetic product. It is a liquid used for skin or hair.

What's happening? The product contains a chemical called BMHCA. This chemical is banned in cosmetics. It may harm the reproductive system, unborn babies, and skin.

Does this affect me? Anyone using this product in the UK may be at risk. Pregnant women and people with sensitive skin are more at risk.

What should I do? Stop using this product right away. Ask your pharmacist or doctor if you have any health concerns.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Brand(s) / product name(s)
Agency-published detail

Risk level: Serious risk · Type: Chemical · Category: Cosmetics · Hazard: The product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause skin sensitisation. · Origin: India

First published
March 6, 2026
Last refreshed by us
1 week ago
Severity (as classified)
High
Official source
https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10097995

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

What is this product recall alert about?
Bajaj — Almond Drops. Risk level: Serious risk · Type: Chemical · Category: Cosmetics · Hazard: The product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the unborn child and may cause s...
When was this alert issued?
This alert was issued on March 6, 2026 by EU Safety Gate.
Which countries are affected?
The alert applies to UNITED KINGDOM IN RESPEC.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you have this product at home, stop using it and return it to the point of purchase for a refund. Keep the receipt if you have one — most retailers refund without it for safety recalls.
Where can I find the official notice?
The full official notice is published on ec.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.